Clinical response to inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn

Journal of Korean Medical Science

Volumn 13, Issue 5, 1998, Pages 500-506

  Ko, Sun Young ^a   Chang, Yun Sil ^a   Park, Won Soon ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Nitric oxide; Persistent pulmonary hypertension of the newborn; Respiratory therapy

Indexed keywords

NITRIC OXIDE; VASODILATOR AGENT;

ARTICLE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NEWBORN; PERSISTENT FETUS CIRCULATION; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; HUMANS; INFANT, NEWBORN; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0032176453     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1998.13.5.500     Document Type: Article

References (31)

1. Gersony WM, Duc GV, Sinclair JC. "PFC" syndrome (persistent of the fetal circulation). Circulation 1969; 40(Supp13): 87.
2. Gersony WM. Neonatal pulmonary hypertension: pathophysiology, classification and etiology. Clin Perinatol 1984; 11: 517-24.
3. Drummond WH, Peckam GJ, Fox WW. The clinical profile of the newborn with persistent pulmonary hypertension. Clin Pediatr 1977; 16: 335-41.
4. Roberts JD, Shaul PW. Advances in the treatment of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am 1993; 40: 983-1004.
5. Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JB. Extracorporeal circulation in neonatal respiratory failure; a prospective randomized study. Pediatrics 1985; 76: 479-87.
6. Hageman JR, Adams MA, Gardner TH. Pulmonary complications of hyperventilation therapy for persistent pulmonary hypertension. Crit Care Med 1985; 13: 1013-4.
7. Hofkosh PE, Thompson AE, Nozza RJ. Ten years of extracorporeal membrane oxygenation. Pediatrics 1991; 87: 549-55.
8. Abman SH, Chatfield BA, Rodman DM, Hall SL, McMurty IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990; 259: H1921-7.
9. Davidson D, Eldermedash A. Endothelium-derived relaxing factor: evidence that it regulates pulmonary vascular resitance in the isolated newborn guinea pig lung. Pediatr Res 1991; 29: 538-42.
10. Tiktinsky MN, Morin FC. Increasing oxygen tension dilates fetal pulmonary circulation by endothelium-derived relaxing factor. Am J Physiol 1993; 265: H376-80.
11. Roberts JD, Polander DM, Lang P, Zapol WM. Inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-9.
12. Kinsella JP, Neish SR, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 819-20.
13. Chang YS, Park WS, Choi JH, Yun CK. Hemodynamic effect of nitric oxide inhalation in the acute hypoxic pulmonary hypertension induced newborn piglet. J Korean Pediatr Soc 1997; 40: 1394-409.
14. Chang YS, Kang IS, Park WS, Lee SK, Kim HH, Lee HJ. Two cases of nitric oxide inhalation for treatment of severe pulmonary hypertension after surgical repair of congenital diaphragmatic hernia. J Korean Pediatr Soc 1996; 39: 1611-9.
15. Walsh-Sucks MC. Persistent pulmonary hypertension of the newborn; the black box revisited. Clin Percental 1993; 20: 127-43.
16. Palmer RAJ, Ferrite EG, Monacle S. Nitric oxide release accounts for the biologic activity of endothelial-derived relaxing factor. Nature 1987; 327: 524-6.
17. Ignazio LA, Barns RE, Bugs GM. Endothelial-derived relaxing factor form pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Cir Res 1987; 61: 866-79.
18. Rodman DA. Effects of hypnosis on endothelial-dependent relaxation of rat pulmonary artery. Am J Physiol 1990; 258: 1207-14.
19. Roberts AD, Planer DA, Toadery ID, Lang P, Zapol WM. Inhaled nitric oxide (NO): a selective pulmonary vasodilator for the treatment of persistent pulmonary hypertension of the newborn (PPHN). Circulation 1991; 84: A1279.
20. Ronald WD, Joanna ML, Keith SW, Robert MW. Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics 1996; 98: 698-705.
21. Karamanoukian HL, Glick PL, Zayek M, Steinhorn RH, Zwass MS, Fienman JR, Morin FC. Inhaled nitric oxide in congenital hypoplasia of lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics 1994; 94: 715-8.
22. Waffarn F, Turbow R, Yang L, Sills J, Hallman M. Treatment of persistent pulmonary hypertension of the newborn: a randomized trial comparing intermittent mandatory ventilation and high frequency oscillatory ventilation for delivery nitric oxide. Pediatr Res 1995; 37: 243A.
23. Evans NJ, Archer LNJ. Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of hyaline membrane disease. Arch Dis Child 1991; 66: 6-11.
24. Abman SH, Kinsella JP, Schaffer MS, Wilkening RB. Inhaled nitric oxide therapy in a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics 1993; 92: 606-9.
25. Turbow R, Waffarn F, Yang L, Sills J, Hallman M. Variable oxygenation response to inhaled nitric oxide in severe persistent pulmonary hypertension of the newborn. Acta Paediatr 1995; 84: 1305-8.
26. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of PPHN with low doses of inhaled NO. J Pediatr 1993; 123: 103-8.
27. Szabo C, Thiemermann C, Wu C, Perretti M, Vane J. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids account for endotoxin tolerance in vivo. Proc Natl Acad Sci USA 1994; 91: 271-5.
28. Radermacher P, Santak P, Becker H, Falke KJ. Prostaglandin El and nitroglycerin induced pulmonary capillary pressure but worsen V/Q distribution in patient with adult respiratory distress syndrome. Anesthesiology 1989; 70: 601-9.
29. Wessel DL, Adatla I, Thompson JE, Mickey PR. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 1994; 22: 930-8.
30. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997; 336: 597-604.
31. The Inhaled Nitric Oxide Study Group. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997; 336: 605-10.